发明名称 Piperazine compounds and medicinal use thereof
摘要 Piperazine compounds represented by the following general formula (I) or pharmaceutically acceptable salts thereof and drugs comprising these compounds, wherein R<1> and R<2> represent each hydrogen, halogeno, lower alkyl, lower alkoxy, optionally substituted amino, nitro, hydroxy or cyano; R<3>, R<4> and R<5> represent each hydrogen, halogeno, lower alkyl, lower alkoxy, nitro, optionally substituted amino or hydroxy; R<6> and R<7> represent each hydrogen, optionally halogenated lower alkyl, aralkyl, acyl or halogenated lower acyl; R<8> and R<9> represent each hydrogen or lower alkyl; Y represents lower alkylene, etc.; and the ring A represents phenyl, pyrimidyl, thiazolyl, pyridyl, pyrazyl or imidazolyl. Because of having excellent TNF- alpha production inhibitory effect and/or IL-10 production promoting effect, these compounds are useful as TNF- alpha production inhibitors and/or IL-10 production promoters with high safety. They are useful as preventives or remedies for, e.g., chronic inflammatory diseases, acute inflammatory diseases, inflammatory diseases caused by infection, autoimmune diseases, allergic diseases and other TNF- alpha -mediated diseases. <CHEM>
申请公布号 AU744577(B2) 申请公布日期 2002.02.28
申请号 AU19980094604 申请日期 1998.10.13
申请人 WELFIDE CORPORATION 发明人 KUNITOMO ADACHI;YOSHIYUKI AOKI;TOKUSHI HANANO;HIROSHI MORIMOTO;MASAO HISADOME
分类号 C07D295/12;A61K31/495;A61P19/02;C07D213/00;C07D213/74;C07D233/00;C07D233/90;C07D239/00;C07D239/42;C07D239/46;C07D239/47;C07D239/48;C07D239/52;C07D239/54;C07D239/545;C07D277/00;C07D277/42;C07D277/58;C07D295/135;C07D401/04;C07D403/04;C07D417/04 主分类号 C07D295/12
代理机构 代理人
主权项
地址